| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:(-)-Xestospongin C;(1R,4aR,11R,12aS,13S,16aS,23R,24aS)-Eicosahydro-5H,17H-1,23:11,13-diethano-2H,14H-[1,11]dioxacycloeicosino[2,3-b:12,13-b']dipyridine
CAS:88903-69-9
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:Xestospongin C
CAS:88903-69-9
Purity:film Package:50UG Remarks:X2628-50UG
|
- Xestospongin C
-
- $209.00 / 10μg
-
2026-03-12
- CAS:88903-69-9
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | XESTOSPONGIN C Basic information |
| Product Name: | XESTOSPONGIN C | | Synonyms: | ARGUSPONGINE E;[1R-(1R*,4AR*,11R*,12AS*,13S*,16AS*,23R*,24AS*)]-EICOSAHYDRO-5H,17H-1,23:11,13-DIETHANO-2H,14H-[1,11]DIOXACYCLOEICOSINO[2,3-B:12,13-B']DIPYRIDINE;XESTOSPONGIN C;XEC;XESTOSPONGIN;(1R,4aR,11R,12aS,13S,16aS,23R,24aS)-Eicosahydro-5H,17H-1,23:11,13-diethano-2H,14H-[1,11]dioxacycloeicosino[2,3-b:12,13-b']dipyridine;PQYOPBRFUUEHRC-HCKQMYSWSA-N;5H,17H-1,23:11,13-Diethano-2H,14H-[1,11]dioxacycloeicosino[2,3-b:12,13-b']dipyridine, eicosahydro-, (1R,4aR,11R,12aS,13S,16aS,23R,24aS)- | | CAS: | 88903-69-9 | | MF: | C28H50N2O2 | | MW: | 446.71 | | EINECS: | | | Product Categories: | | | Mol File: | 88903-69-9.mol |  |
| | XESTOSPONGIN C Chemical Properties |
| Melting point | 146-147 °C(Solv: acetone (67-64-1)) | | Boiling point | 564.7±35.0 °C(Predicted) | | density | 1.05±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | DMSO: soluble | | pka | 7.73±0.20(Predicted) | | form | film | | color | off-white | | Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month. | | InChIKey | PQYOPBRFUUEHRC-HCKQMYSWSA-N | | SMILES | [H][C@@]12CCCCCC[C@@]3([H])CCCN4CC[C@@]([H])(CCCCCC[C@]5([H])CCCN(CC1)[C@@]5([H])O2)O[C@@]34[H] |
| WGK Germany | 3 | | Storage Class | 11 - Combustible Solids |
| | XESTOSPONGIN C Usage And Synthesis |
| Description | Xestospongin C (88903-69-9) is a potent and reversible inhibitor of IP3-mediated Ca2+release, IC50= 358 nM.1Experiments with guinea-pig ileum permeabilized with alpha toxin revealed that Xestospongin C inhibits the IP3 receptor but not the ryanodine receptor in SR membranes. In intact smooth muscle cells it inhibits voltage-dependent Ca2+and K+currents at a concentration range similar to that at which it inhibits the IP3 receptor. Xestospongin C is a useful tool for probing the involvement of IP3 receptors in cellular signaling.3Cell permeable. | | Uses | Xestospongin C is a marine natural product which was first isolated from Pacific basin sponges, and noted to have vasodilatory properties. Xestospongin C antagonizes the calcium-releasing action of inositol-1,4,5-trisphosphate (IP3) at the receptor level. Inositol phosphates are important signal transduction messengers acting via IP3 receptors to promote the mobilization of Ca2+ from intracellular stores. Xestospongin C blocks the increase in intracellular calcium in vascular smooth muscle cells completely at a concentration of 25 μM. Xestospongin C also inhibits the sarcoplasmic reticulum Ca2+ ATPase pump at concentrations of 700 nM. | | Uses | Xestospongin C is a potent, membrane-permeable IP3 receptor blocker. | | Definition | ChEBI: An organic heteropentacyclic compound that is isolated from the marine sponge Xestospongia exigua. | | General Description | Synthetic form of the macrocyclic bis-1-oxaquinolizidine isolated from the Okanowan marine sponge. | | Biochem/physiol Actions | Xestospongin C is a selective, reversible and membrane-permeable inhibitor of IP3 receptor. Reversibly blocks bradykinin- and carbamylcholine- Ca2+ efflux from the endoplasmic reticulum stores. | | storage | Store at -20°C | | References | [1] R A WILCOX. New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor.[J]. Trends in pharmacological sciences, 1998, 19 11: 467-475. DOI:10.1016/s0165-6147(98)01260-7
[2] HIROSHI OZAKI. Inhibitory mechanism of xestospongin-C on contraction and ion channels in the intestinal smooth muscle[J]. British Journal of Pharmacology, 2009, 137 8: 1207-1212. DOI:10.1038/sj.bjp.0704988
[3] KATHIRVEL KANDASAMY. Lipopolysaccharide induces endoplasmic store Ca2+-dependent inflammatory responses in lung microvessels.[J]. PLoS ONE, 2013: e63465. DOI:10.1371/journal.pone.0063465 |
| | XESTOSPONGIN C Preparation Products And Raw materials |
|